CCR8 and cancer: These findings are consistent with our observation that CCR8 plays a critical role in Treg-mediated immune regulation, highlighting the therapeutic potential of targeting the CCL1–CCR8 axis to modulate Treg function and improve cancer immunotherapy outcomes.